Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of age.
Diaz C, Dentico P, Gonzalez R, Mendez RG, Cinquetti S, Barben JL, Harmon A, Chalikonda I, Smith JG, Stek JE, Robertson A, Caulfield MJ, Biasio LR, Silber JL, Chan CY, Vessey R, Sadoff J, Chan IS, Matthews H, Wang W, Schlienger K, Schödel FP; Protocol 049 Study Group.
Diaz C, et al. Among authors: matthews h.
Vaccine. 2006 Nov 17;24(47-48):6875-85. doi: 10.1016/j.vaccine.2006.06.030. Epub 2006 Jul 7.
Vaccine. 2006.
PMID: 17050042
Clinical Trial.